Data / Form D filings / Tiger Biotherapeutics Inc.
Tiger Biotherapeutics Inc.: Form D filing
Tiger Biotherapeutics Inc., a technology company in Cranbury, NJ, filed a Form D with the SEC in 2023. The latest, on April 5, 2023, reports $20 million sold of a $22 million offering to 4 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 8 CLARKE DRIVE, SUITE 4, Cranbury, NJ, 08512
- Phone
- (646) 462-5083
- Industry
- Other Technology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2023
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1972279
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Apr 5, 2023 | New notice | $22,000,230 | $20,000,230 | $2,000,000 | 4 | Mar 23, 2023 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Jie FAN | Executive Officer, Director | |
| Quan ZHOU | Director | |
| Bihua Chen | Director |
Other technology companies in New Jersey that filed recently
- Memazing, Inc. $15.4 million · Oct 16, 2026
- Pocket Bard Inc. $28,650 · Oct 13, 2026
- Ritrova Inc. $1.5 million · Oct 9, 2026
- Smirta Innovations Inc $2 million · Oct 2, 2026
- RenewCO2 Inc. $9.3 million · Sep 29, 2026
- Liife, Inc. $2.2 million · Sep 22, 2026
Every Form D from the week of Apr 3, 2023 · All recent filings in New Jersey · All recent Other Technology filings
Read from SEC EDGAR. Amount sold is what Tiger Biotherapeutics Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.